返回
Scaling Predictive Modeling in Drug Development with Cloud Computing
DOI:10.1021/ci500580y.png)
摘要
En 中文
Growing data sets with increased time for analysis is hampering predictive modeling in drug discovery. Model building can be carried out on high-performance computer clusters, but these can be expensive to purchase and maintain. We have evaluated ligand-based modeling on cloud computing resources where computations are parallelized and run on the Amazon Elastic Cloud. We trained models on open data sets of varying sizes for the end points logP and Ames mutagenicity and compare with model building parallelized on a traditional high-performance computing cluster. We show that while high-performance computing results in faster model building, the use of cloud computing resources is feasible for large data sets and scales well within cloud instances. An additional advantage of cloud computing is that the costs of predictive models can be easily quantified, and a choice can be made between speed and economy. The easy access to computational resources with no up-front investments makes cloud computing an attractive alternative for scientists, especially for those without access to a supercomputer, and our study shows that it enables cost-efficient modeling of large data sets on demand within reasonable time.
Keyword:
SIGNATURE MOLECULAR DESCRIPTOR
DEVELOPMENT KIT CDK
SOURCE JAVA LIBRARY
QUANTITATIVE STRUCTURE
AQUEOUS SOLUBILITY
HIGH-PERFORMANCE
QSAR
DISCOVERY
CARCINOGENICITY
FRAMEWORK
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.3
论文数:
9.2K
被引数:
4.0W
机构
引用论文
Obstructive sleep apnea classification based on spectrogram patterns in the electrocardiogram基于心电图谱图模式的阻塞性睡眠呼吸暂停分类
Lessons learned from implementing a national infrastructure in Sweden for storage and analysis of next-generation sequencing data
GIGASCIENCE
IF3.9

